SecBot SecBot
25-NSE ·Filed Oct 13, 2026

ALUR

ALLURION TECHNOLOGIES, INC.
BEARISH
Impact 7/10
Horizonimmediate Processed13d 16h ago SEC0000876661-26-000826
Notable filing: 25-NSE
Actionable Insight ▼ Bearish

The delisting is final with no further appeal options. Monitor for potential OTCQX or OTCQB listing and any restructuring or reverse-split attempts to regain compliance. The prior NT 10-Q indicates ongoing financial reporting delays.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+5d
ALUR ▲ 0.00% at T+5d
SHORT call ✗ call lost 0.00% · α vs SPY -1.15% · entry $0.6711 → $0.6711
Next anchor: T+20d in 14d
Latest observation: T+7 -41.73% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.08%
$0.6711
settled 13d ago
T+5d
0.00%
call 0.00% · α -1.15%
$0.6711
settled 7d ago
T+20d
Pending
in 14d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

The New York Stock Exchange filed a Form 25-NSE to delist Allurion Technologies' common stock and warrants, effective October 26, 2026, because the company's average global market capitalization fell below the NYSE's $15 million continued listing standard over 30 consecutive trading days. Trading was suspended on March 6, 2026, and the company withdrew its appeal on July 2, 2026, making the delisting final.

Key Facts

  • NYSE filed Form 25-NSE to delist Allurion Technologies' common stock and warrants
  • Delisting effective October 26, 2026
  • Average global market capitalization fell below $15 million over 30 consecutive trading days
  • Trading suspended on March 6, 2026
  • Company withdrew its appeal on July 2, 2026
  • Prior NT 10-Q filed August 14, 2026 for late quarterly report

Financial Impact

Delisting from NYSE eliminates exchange listing, likely triggering further price decline and reduced liquidity; market cap had already fallen below $15 million threshold

market capitalizationliquiditylisting status

Risk Factors

  • Complete loss of exchange listing and trading liquidity
  • Potential default on debt covenants tied to NYSE listing
  • Risk of further regulatory non-compliance and SEC enforcement
  • Limited access to capital markets going forward

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0000876661-26-000826
Document: 0000876661-26-000826-index.html0000876661-26-000826
Document: 0000876661-26-000826.txt0000876661-26-000826
5 reports for ALUR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ALUR — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
25-NSE
BEARISH ★ 7/10
$0.6711 $0.6711· 0.00%▼ −1.15%$0.010000 (+98.51%)
Jul 23, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.6711 $0.6711· 0.00%▲ +1.10%$0.010000 (+98.51%)
Jul 7, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$0.6711 $0.6711· 0.00%▼ −0.55%$0.010000 (−98.51%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$4.80 $5.32▲ +10.77%▲ +10.82%$0.010000 (−99.79%)
Feb 25, 2026
34w ago
8-K
NEUTRAL ★ 4/10
$1.23 $0.7590▼ −38.29%▼ −37.19%$0.010000 (−99.19%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026